Both in Biotechnology
Vir Biotechnology vs Maze Therapeutics
Over the past year VIR returned +96.4% and MAZE returned −8.6%; their daily moves had a correlation of 0.26.
VIR +96.4% MAZE −8.6%Growth of $1, one year, split-adjusted
| Metric | VIR | MAZE |
|---|---|---|
| Price | $11.00 | $30.37 |
| Market cap | $1.86B | $1.69B |
| Today | −2.65% | −3.53% |
| 1 month | −1.5% | +14.9% |
| 6 months | +8.1% | +12.8% |
| Year to date | +82.4% | −26.7% |
| 1 year | +85.5% | −8.6% |
| Revenue growth (YoY) | +19582.5% | — |
| Gross margin | 100.0% | — |
| Net margin | 33.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.1× | 84.4× |
| Net cash | $532.7M | $372.1M |
| Dividend yield | — | — |
| Volatility (60d) | 51.4% | 67.1% |
| Short % of float | 12.3% | 18.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).